Search

for
Search:

Sort by

Research

900-930 / 1000+ results

Photostability and Toxicity of Finasteride, Diclofenac, and Naproxen Under Simulated Sunlight Exposure: Evaluation of the Toxicity Trend and Packaging Photoprotection

research Photostability and toxicity of finasteride, diclofenac and naproxen under simulating sunlight exposure: evaluation of the toxicity trend and of the packaging photoprotection

13 citations , December 2013 in “Chemistry Central Journal”

Sunlight exposure increases drug toxicity; amber glass best for protection.

Deferoxamine Protects Cochlear Hair Cells Against Tert-Butyl Hydroperoxide-Induced Ototoxicity

research Deferoxamine protects cochlear hair cells and hair cell-like HEI-OC1 cells against tert-butyl hydroperoxide-induced ototoxicity

March 2024 in “Biochimica et biophysica acta. Molecular basis of disease”

Deferoxamine may help protect inner ear cells from damage caused by oxidative stress.

Hair Growth Effects of Oral Administration of Finasteride, a Steroid 5 Alpha-Reductase Inhibitor, Alone and in Combination with Topical Minoxidil in the Balding Stumptail Macaque

research Hair growth effects of oral administration of finasteride, a steroid 5 alpha-reductase inhibitor, alone and in combination with topical minoxidil in the balding stumptail macaque.

34 citations , February 1992 in “The Journal of Clinical Endocrinology and Metabolism”

Finasteride and minoxidil together promote hair growth better than either alone.

research Long-term experiences with minoxidil in combination treatment of severe arterial hypertension.

6 citations , January 1977 in “PubMed”

Minoxidil effectively lowers severe high blood pressure long-term but isn't for routine use.

research Minoxidil opens mitochondrial K_ATP channels and confers cardioprotection

28 citations , January 2004 in “British Journal of Pharmacology”

Minoxidil protects heart and improves recovery.

research Application of the waiting time distribution in a nationwide screening of real‐world dermatology drug utilization for aberrant use patterns

October 2023 in “Pharmacoepidemiology and Drug Safety”

Most dermatology drugs in Denmark are used correctly, with few unusual patterns.

research The preparation of high minoxidil loaded transfersomes and its gel for effective topical treatment of alopecia

April 2023 in “Journal of Drug Delivery Science and Technology”

The new minoxidil gel improves hair growth and reduces skin irritation.

research Successful treatment of perifolliculitis capitis abscedens et suffodiens with combined isotretinoin and dapsone

22 citations , October 2007 in “JDDG Journal der Deutschen Dermatologischen Gesellschaft”

Combining isotretinoin and dapsone effectively treated a challenging scalp condition.

research Increasing utility of finasteride for frontal fibrosing alopecia

7 citations , May 2015 in “Journal of The American Academy of Dermatology”

Finasteride helps treat frontal fibrosing alopecia, improving or stabilizing the condition in many patients.

research Minoxidil for severe hypertension after failure of other hypotensive drugs.

86 citations , September 1977 in “BMJ”

Minoxidil effectively controls blood pressure in severe cases, but has serious side effects and causes hair growth in women.

A Single Topical Application of Calcipotriol (50 µg/g) Ointment Has No Acute Effect on Systemic Calcium Homeostasis in Patients with Chronic Plaque Psoriasis

research A single topical application of calcipotriol (50μg/g) ointment has no acute effect on systemic calcium homeostasis in patients with chronic plaque psoriasis

July 1996 in “Clinical and Experimental Dermatology”

Putting calcipotriol ointment on the skin once doesn't change calcium levels in the body right away.

Evaluation of Topical Sodium Valproate-Loaded Nano Spanlastics Formulation Versus Minoxidil 5% in the Treatment of Female Pattern Hair Loss Using Transdermal Delivery: A Comparative Study

research Evaluation of Topical Sodium Valproate-Loaded Nano Spanlastics Formulation versus Minoxidil® 5% in The Treatment of Female Pattern Hair Loss Using Transdermal Delivery: A Comparative Study

January 2023 in “The Egyptian Journal of Hospital Medicine”

Topical Valproic acid and 5% Minoxidil both significantly increase hair count in Female Pattern Hair Loss, with similar side effects.

research PD16-01 NEW INSIGHT OF PSA REDUCTION DURING FINASTERIDE THERAPY

March 2015 in “The Journal of Urology”

Finasteride reduces PSA levels by around 40-50% in BPH patients.

research Finasteride < Rec INN; BAN; USAN >

5 citations , January 1991 in “Drugs of The Future”

Efficacy and Safety of Once-Daily Minoxidil Foam 5% Versus Twice-Daily Minoxidil Solution 2% in Female Pattern Hair Loss: A Phase III, Randomized, Investigator-Blinded Study

research Faculty Opinions recommendation of Efficacy and Safety of Once-Daily Minoxidil Foam 5% Versus Twice-Daily Minoxidil Solution 2% in Female Pattern Hair Loss: A Phase III, Randomized, Investigator-Blinded Study.

September 2016 in “Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature”

Once-daily 5% minoxidil foam increases hair regrowth and density in women with hair loss, but not as effectively as twice-daily 2% minoxidil solution, though it's safer and more convenient.

$Adjuvant Treatment with Oral Minoxidil for Refractory Alopecia Areata to JAK Inhibitors$

research Tratamento adjuvante com minoxidil oral para tratamento de alopecia areata refratária a inibidores de JAK

1 citations , January 2020 in “Surgical & Cosmetic Dermatology”

Combining oral minoxidil with JAK inhibitors helps regrow hair in severe alopecia areata cases.

research Finasteride 98319‐26‐7

October 2012 in “Sax's Dangerous Properties of Industrial Materials”

research
Calcipotriol Plus Betamethasone Dipropionate Aerosol Foam For Scalp Psoriasis

9 citations , September 2019 in “Clinical Cosmetic and Investigational Dermatology”

Cal/BD aerosol foam effectively treats scalp psoriasis, improving symptoms and patient satisfaction.

research Finasteride improves male pattern hair loss in a randomized study in identical twins.

15 citations , April 2002 in “PubMed”

Finasteride effectively treats male pattern hair loss without serious side effects.

research A phase I study of MK-5108, an oral aurora A kinase inhibitor, in both monotherapy and in combination with docetaxel in patients with advanced solid tumors.

12 citations , May 2010 in “Journal of Clinical Oncology”

MK-5108 is safe and shows potential against tumors, especially alone.

Encapsulation In Cyclodextrins Of Compounds With Activity Against Male Androgenetic Alopecia

research Encapsulación en ciclodextrinas de compuestos con actividad frente a la alopecia androgénica masculina.

January 2021 in “RIUCAM”

Encapsulating hair loss drugs in cyclodextrins improves their solubility and reduces scalp irritation.

Logic-Based Modeling and Drug Repurposing for the Prediction of Novel Therapeutic Targets and Combination Regimens Against E2F1-Driven Melanoma Progression

research Logic-based modeling and drug repurposing for the prediction of novel therapeutic targets and combination regimens against E2F1-driven melanoma progression

1 citations , November 2023 in “BMC chemistry”

Tadalafil and Finasteride may help treat aggressive melanoma.

research Risk assessment of the top 60 drugs for drug-related sexual dysfunction: a disproportion analysis from the Food and Drug Administration adverse event reporting system

August 2025 in “The Journal of Sexual Medicine”

Finasteride, dutasteride, and silodosin have the highest risk for causing sexual dysfunction.

research Gynostemma pentaphyllum Hydrodistillate and Damulin B Prevent UVB‐Induced Photoaging In Vitro and In Vivo via ROS Suppression and Restoration of MAPK/AP‐1 and TGF‐β/Smad Signaling

January 2026 in “Molecular Nutrition & Food Research”

Gynostemma pentaphyllum and Damulin B help prevent skin aging from UVB by reducing oxidative stress and improving skin health.

research Dermpath & Clinic: Telangiectasia macularis eruptiva perstans

July 2022 in “European Journal of Dermatology”

Brodalumab is more effective than ustekinumab in treating psoriasis.

Is the Safety of Finasteride Correlated With Its Route of Administration: Topical Versus Oral? A Pharmacovigilance Study With Data From the United States Food and Drug Administration Adverse Event Reporting System

research Is the Safety of Finasteride Correlated With Its Route of Administration: Topical Versus Oral? A Pharmacovigilance Study With Data From the United States Food and Drug Administration Adverse Event Reporting System

July 2025 in “International Journal of Dermatology”

Topical finasteride may be safer than oral finasteride, but more research is needed.

Cutaneous Adverse Reactions Associated With Enfortumab Vedotin: A Pharmacovigilance Study Based on the FDA Adverse Event Reporting System

research Cutaneous adverse reactions associated with enfortumab vedotin: a pharmacovigilance study based on the FDA adverse event reporting system

April 2026 in “Frontiers in Medicine”

Enfortumab vedotin can cause skin issues, especially in older males, needing early monitoring.

Usefulness of the Vasodilator Minoxidil in Resistant Hypertension

← Previous page Next page →